1. Nice St Paul Breast Cancer Guidelines : 2013 5 topics : - Axillary nodal exploration - Tumor Proliferation - Treatment resistance - Neoadjuvant treatments - T1ab tumors…

1. Place  et  rôle  du  radiothérapeute  dans  le  TNA   Place  of  the  radiotherapy  in  NA  treatment   [email protected] Jerusalem, 30th April 2014…

1. Herceptin ® in the adjuvant setting 2. Herceptin ® in the adjuvant setting: rationale HER2 overexpression is an early event in breast cancer development and is associated…

1. SYMPOSIUMTRASTUZUMAB IN EARLY BREAST CANCER 29/05/2012 DR. R. RAJKUMARII YR POST GRADUATE DEPT OF MEDICAL ONCOLOGY MADRAS MEDICAL COLLEGECHENNAI 2. QUESTION• Trastuzumab:…

1. Technical Progress and Role of External RT in Thyroid Cancer Yong Chan Ahn, MD/PhD Dept. of Radiation Oncology SMC/SKKU SOM 2. In Treating Thyroid Cancer… • Role of…

1. ANGIO2014The 16th International Symposium onAnti-Angiogenic Therapy: Recent Advances and Future Directions in Basic and Clinical Cancer ResearchFebruary 6–8,…

ANGIO 2014 The 16th International Symposium on Anti-Angiogenic Therapy: Recent Advances and Future Directions in Basic and Clinical Cancer Research February 6â8, 2014 Hyatt…

Slide 1 Tissue biomarkers (BIOM) in colon cancer (COC): The translational study on the randomized phase III trial comparing infused irinotecan / 5-fluorouracil (5-FU)/folinic…

Slide 1 INNOVAZIONI TERAPEUTICHE IN ONCOLOGIA MEDICA CAGLIARI 23-24 GIUGNO 2005 LE TERAPIE A TARGET MOLECOLARE: UNA EVOLUZIONE EPOCALE DELLA TERAPIA ANTINEOPLASTICA GIOVANNI…

Slide 1 Adjuvante therapie van het coloncarcinoom anno 2004-2005: is 5FU/LV nog steeds de standaard? Prof.dr. C.J.A. Punt afd. Medische Oncologie UMC St. Radboud Nijmegen…